cubist

Showing 6 posts of 6 posts found.

Merck logo

Merck launches new antibiotic in the UK

June 5, 2015
Research and Development, Sales and Marketing AMR, Antibiotics, MSD, Merck, Sivextro, antimicrobial resistance, cubist, tedizolid phosphate

Merck has launched the first new drug in a class of antibiotics in the UK in almost 15 years, becoming …

michael_w

Celgene appoints former Cubist chief executive

April 20, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, cubist, michael bonney

Celgene has elected pharma veteran Michael Bonney to join its board of directors. Bonney served as chief executive and board …

Zerbaxa

Cubist boosts antibiotics market presence

December 22, 2014
Sales and Marketing Antibiotics, Zerbaxa, antimicrobial resistance, bacteria, cubist, infections, infectious diseases

Cubist has followed-up its successful European approval for a new antibiotic by winning an endorsement by the US FDA. The …

Merck image

Merck acquires Swiss firm OncoEthix

December 19, 2014
Sales and Marketing Cancer, FDA, Merck, OTX015, cubist, keytruda, oncoethix, pembrolizumab

Hot on the heals of its Cubist buyout Merck has confirmed the acquisition of OncoEthix, a Swiss based firm which …

Merck image

Updated: Merck buys antibiotics specialist Cubist

December 8, 2014
Sales and Marketing Antibiotics, Merck, Novartis, cubicin, cubist, eumer

Merck has purchased US antibiotics maker Cubist in a deal valued at $9.5 billion. The acquisition values Cubist at around …

perez

Cubist Pharmaceuticals names chief executive

October 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cubist, perez

US biopharma firm Cubist Pharmaceuticals has named Robert Perez as its chief executive and who will begin the role from …

Latest content